Adebayo Alonge

Adebayo Alonge is a Nigerian pharmacist, inventor, deep tech entrepreneur, and market development professional. He emerged as the winner of the 2019 Hello Tomorrow Global deeptech Challenge otherwise known as, BNP Paribas Group Deep Tech Award, for creating a handheld nanoscanner that detects counterfeit drugs. He is the first African to win the contest.[1]

MNIM

Adebayo Alonge
Adebayo Alonge, 2019.
NationalityNigerian
Other namesSamuel
Alma materKing's College, Lagos
(Senior School Certificate)
University of Ibadan
(Bachelor of Pharmacy)
Lagos Business School
(Master of Business Administration)
Yale School of Management
(Master of Advanced Management)
John F. Kennedy School of Government
(Master of Public Administration)
Graduate School of International Corporate Strategy
(International business)
Known forinvention of RxScanner
AwardsAwards in person from Barack Obama (ex-US president) and Justin Trudeau (prime minister of Canada)

Regional finalist, Hult Prize Global Case Competition

Young Innovator – YouWin!

Grand Winner & Digital Health Winner, Hello Tomorrow Global Challenge 2019

Winner, deep tech Award with a €100,000 prize, 2019

2018 China Award for Best deep tech Platform in the World

Global Social Venture Award (2016) from InnovateHealth, Yale

Mandela Washington Fellowship from the United States Department of State for outstanding contributions to business and entrepreneurship in Africa (2014)

Adekunle Ajasin Award for Academic Excellence in 2008

He is the CEO and co-founder of [2]RxAll Inc. – a U.S based deep tech Start-up firm.[3]

Education

Adebayo Alonge attended[4] King's College, Lagos, between 1996–2002. He studied pharmacy at University of Ibadan, and graduated with first class honor in 2008.[5] He had Master of Business Administration degree (with focus on Strategy and Finance) at the Lagos Business School - Pan-Atlantic University and holds Master of Advanced Management from Yale University - Yale School of Management.[6] He is an alumnus of Hitotsubashi University Graduate School of International Corporate Strategy, and currently studying Master of Public Administration (Mason Program) at Harvard Kennedy School - Harvard University.[7]

Career

Adebayo Alonge served in the following capacity as: Medical representative of Sanofi between November 2009 and September 2010; Contract Pharmacist at Global HIV/AIDS Initiative; Medical representative of Roche (now Swiss Pharma Nigeria) from September 2010 to October 2012; Market development Intern[8](Pharma Ingredients) of BASF between July 2013 to October 2013; Market Developer at BASF West Africa from August 2014 to August 2015; Director of business development at Lusoy Investments Limited between April 2012 to October 2017; and Consultant at The Boston Consulting Group from November 2015 to October 2017.[9]

In 2016, Alonge co-founded RxAll Inc., with the intention of preventing patients from counterfeit medicines and provide a way for them to authenticate their drugs. The RxAll team has essentially three co-founders, Alonge as the Chief executive official, Amy Kao as the Chief marketing officer, and Wei Liu as the Chief technology officer.[10]

Awards, Honours and Recognition

Adebayo Alonge is the recipient of the following awards: Adekunle Ajasin Award for Academic Excellence in 2008; Mandela Washington Fellowship from[11] the United States Department of State for outstanding contributions to business and entrepreneurship in Africa (2014); Global Social Venture Award (2016) from InnovateHealth, Yale; 2018 China Award for Best DeepTech Platform in the World;[12] Winner, Deep Tech Award with a €100,000 prize, 2019; Grand Winner & Digital Health Winner, Hello Tomorrow Global Challenge 2019; Young Innovator – YouWin!; Regional finalist, Hult Prize Global Case Competition; and awards in person from Barack Obama (ex-US president) and Justin Trudeau (prime minister of Canada).

gollark: It should probably be fine.
gollark: Oh, I used one of those for a thing, the drift was fine and the magnetometer probably lets you compensate for it.
gollark: I don't mean a specific one, there are many.
gollark: Some of the nicer ones will even filter noise and work out orientation for you.
gollark: You could just use an IMU with all three of those.

References
  1. "SPOTLIGHT: Meet Adebayo Alonge, the pharmacist fighting fake drugs with deep tech". TheCable Lifestyle. 2019-03-29. Retrieved 2020-01-20.
  2. "Fake pharmaceutical industry thrives in West Africa". BBC News. 2020-07-13. Retrieved 2020-08-07.
  3. "RxAll, Founded by Adebayo Alonge '16, Named Best Early-Stage Startup in Hello Tomorrow Global Challenge". Yale School of Management. 2019-03-21. Retrieved 2020-01-20.
  4. "Startup Saves Lives by Ridding African Market of Counterfeit Drugs". Yale School of Management. 2018-04-06. Retrieved 2020-08-07.
  5. "Five questions to …. Adebayo Alonge – IFPMA". www.ifpma.org. Retrieved 2020-01-20.
  6. "Adebayo Samuel Alonge". IREX. Retrieved 2020-01-20.
  7. am, Amy Xiong 12:21; Apr 06; 2018. "New startup targets fake drugs". yaledailynews.com. Retrieved 2020-08-07.CS1 maint: numeric names: authors list (link)
  8. "Meet Adebayo Alonge, the Nigeran pharmacist who beat Tech startups from 119 countries to win the grand prize of €100,000". www.pulse.ng. Retrieved 2020-01-20.
  9. "Adebayo Samuel Alonge". IREX. Retrieved 2020-01-20.
  10. "Adebayo Alonge". summit.techsauce.co. Retrieved 2020-01-20.
  11. Ekwealor, Victor (2019-03-22). "Nigerian deep tech startup, RxAll is looking to squash the $30 billion global fake drug industry". Techpoint.Africa. Retrieved 2020-01-20.
  12. Ojigbo, Solomon (2019-04-17). "Adebayo Alonge: Inventor of World's First Advanced Drug Authenticator". Pharmanewsonline. Retrieved 2020-01-20.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.